Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade)
Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...